These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 9270089)
1. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms. Fedorova OV; Bagrov AY Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089 [TBL] [Abstract][Full Text] [Related]
2. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries. Bagrov AY; Fedorova OV J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882 [TBL] [Abstract][Full Text] [Related]
7. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism. Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190 [TBL] [Abstract][Full Text] [Related]
8. [Role of the alpha2-isoform of Na+, K(+)-ATPase in the positive inotropic effect of ouabain and marinobufagenin in the rat diaphragm]. Krivoĭ II; Drabkina TM; Kravtsova VV; Vasil'ev AN; Vashchinkina EV; Prokof'ev AV; Kubasov IV Biofizika; 2006; 51(5):906-11. PubMed ID: 17131832 [TBL] [Abstract][Full Text] [Related]
9. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats. Fedorova OV; Anderson DE; Bagrov AY Am J Hypertens; 1998 Jul; 11(7):796-802. PubMed ID: 9683040 [TBL] [Abstract][Full Text] [Related]
10. Selective ligands for Na Chakraborty D; Fedorova OV; Bagrov AY; Kaphzan H Neuropharmacology; 2017 May; 117():338-351. PubMed ID: 28232062 [TBL] [Abstract][Full Text] [Related]
11. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity. Bagrov AY; Dmitrieva RI; Fedorova OV; Kazakov GP; Roukoyatkina NI; Shpen VM Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650 [TBL] [Abstract][Full Text] [Related]
12. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648 [TBL] [Abstract][Full Text] [Related]
13. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation. Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of the interaction between nicotinic acetylcholine receptor and Na+,K(+)-ATPase in the rat skeletal muscle and the Torpedo electric organ membrane preparation]. Krivoĭ II; Drabkina TM; Vasil'ev AN; Kravtsova VV; Mandel F Ross Fiziol Zh Im I M Sechenova; 2006 Feb; 92(2):191-203. PubMed ID: 16739652 [TBL] [Abstract][Full Text] [Related]
15. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474 [TBL] [Abstract][Full Text] [Related]
16. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad. Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009 [TBL] [Abstract][Full Text] [Related]
17. Reduced Na-K pump but increased Na-K-2Cl cotransporter in aorta of streptozotocin-induced diabetic rat. Michea L; Irribarra V; Goecke IA; Marusic ET Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H851-8. PubMed ID: 11158986 [TBL] [Abstract][Full Text] [Related]
18. Effect of Na+ on Na+,K+-ATPase alpha-subunit expression and Na+-pump activity in aortic smooth muscle cells. Liu X; Songu-Mize E Eur J Pharmacol; 1998 Jun; 351(1):113-9. PubMed ID: 9698212 [TBL] [Abstract][Full Text] [Related]